PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
Public ClinicalTrials.gov record NCT00251849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients
Study identification
- NCT ID
- NCT00251849
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ActivBiotics
- Industry
- Enrollment
- 274 participants
Conditions and interventions
Interventions
- Rifalazil Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2005
- Primary completion
- Not listed
- Completion
- Nov 30, 2007
- Last update posted
- Aug 20, 2008
2005 – 2007
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Cardiovascular Research Institute | Scottsdale | Arizona | 85251 | — |
| VA Palo Alto Health Care System | Palo Alto | California | 94304 | — |
| Siddeg, Inc. | San Diego | California | 92103 | — |
| Apex Research Institute | Santa Ana | California | 92705 | — |
| Radiant Research | Santa Rosa | California | 95405 | — |
| Aurora Denver Cardiology Associates | Denver | Colorado | 80218 | — |
| Tampa Bay Medical Research, Inc. | Clearwater | Florida | 33761 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| University Clinical Research | Pembrook Pines | Florida | 33024 | — |
| Cardiovascular Center of Sarasota | Sarasota | Florida | 34239 | — |
| Rockdale Medical Research Associates | Conyers | Georgia | 30094 | — |
| The Care Group | Indianapolis | Indiana | 46290 | — |
| Androscoggin Cardiology Associates | Auburn | Maine | 04210 | — |
| University of Massachusetts Medical Center | Worcester | Massachusetts | 01655 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| Durham VA Medical Center | Durham | North Carolina | 27705 | — |
| New Hope Research of Oregon, Inc. | Portland | Oregon | 97219 | — |
| Radiant Research | Philadelphia | Pennsylvania | 19115 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Black Hills Clinical Research Center | Rapid City | South Dakota | 57701 | — |
| Hampton Roads Center for Clinical Research | Norfolk | Virginia | 23502 | — |
| National Clinical Research | Richmond | Virginia | 23294 | — |
| Care Foundation | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00251849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2008 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00251849 live on ClinicalTrials.gov.